ENDRA LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2525 USD | +4.12% |
|
+2.23% | -88.09% |
| 03-28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
| 03-28 | ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar ENDRA Life Sciences Inc.
b8b52ab72dc6f2a8b2.0Y4BTnBKn-Iif9GUmP_3UIzfKaAmA_OjvKUxSI4LSHA.gt1jICI-_YF2IOnX9IW9Cd3uSMpAZpnz1NJ-IdFEDSmCvFEbQH7zjG1Nvg~ca09df59eed6c93d1574570835499942
Upcoming events on ENDRA Life Sciences Inc.
Past events on ENDRA Life Sciences Inc.
| 28/03/2024 20:30 | Q4 2023 Earnings Call |
| 28/03/2024 20:05 | Q4 2023 Earnings Release |
| 06/12/2023 | Benchmark Company Discovery Conference |
| 14/11/2023 21:30 | Q3 2023 Earnings Call |
| 14/11/2023 21:05 | Q3 2023 Earnings Release |
| 09/11/2023 | American Association for the Study of Liver Diseases Conference |
| 10/10/2023 | DLT Three Lander Meeting |
| 03/10/2023 | AFEF French Association for the Study of the Liver Conference |
| 01/10/2023 | European Association for the Study of Diabetes Conference |
| 23/09/2023 10:00 | European Association for the Study of the Liver Steatotic Liver Disease Summit - Abstract Number : P |
| 18/09/2023 | British Association for the Study of the Liver Meeting |
| 14/08/2023 21:30 | Q2 2023 Earnings Call |
| 14/08/2023 21:05 | Q2 2023 Earnings Release |
| 25/07/2023 15:00 | Annual General Meeting |
| 21/06/2023 15:00 | European Association for the Study of the Liver Congress - Abstract No.: 3381 |
| 15/05/2023 21:30 | Q1 2023 Earnings Call |
| 15/05/2023 21:05 | Q1 2023 Earnings Release |
| 14/03/2023 20:30 | Q4 2022 Earnings Call |
| 14/03/2023 20:05 | Q4 2022 Earnings Release |
| 28/11/2022 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,23 - | 0,00 0,70 - | 0,00 0,00 - | 1,00 |
|
EBITDA Million USD | Released Forecast Spread | -10,8 -10,2 -5.62% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,8 -10,2 -6.44% | -11,5 -12,9 10.84% | -11,5 -11,7 1.73% | -13,2 -12,8 -2.79% | -10,5 -12,2 13.76% | -12,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,3 -10,8 -22.8% | -11,7 -13,1 10.49% | -11,2 -11,5 2.22% | -13,2 -12,9 -2.56% | -10,1 -11,7 14.01% | -12,3 |
|
Net income Million USD | Released Forecast Spread | -17,5 -11,0 -59.07% | -12,1 -13,5 10.21% | -11,4 -11,5 1.6% | -13,2 -12,9 -2.56% | -10,1 -11,7 14.01% | -12,3 |
|
EPS USD | Released Forecast Spread | -46,8 -25,1 -86.83% | -12,6 -14,2 11.27% | -5,60 -5,60 0% | -4,56 -4,40 -3.64% | -1,58 -1,85 14.59% | -1,41 |
| Announcement Date | 26/03/20 | 25/03/21 | 30/03/22 | 14/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,23 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,70 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,10 | 0,10 | 0,30 | 0,50 |
|
EBIT Million USD | Released Forecast Spread | -3,07 -3,24 5.13% | -2,86 -3,20 10.77% | -3,57 -3,05 -17.1% | -3,42 -3,55 3.74% | -3,31 -3,00 -10.45% | -2,94 -3,35 12.26% | -2,99 -3,30 9.26% | -3,13 -3,30 5.18% | -1,50 -3,10 51.61% | -3,20 | -3,20 | -3,10 | -3,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,10 -3,26 4.85% | -2,86 -3,20 10.68% | -3,59 -3,00 -19.7% | -3,44 -3,50 1.71% | -3,29 -3,00 -9.65% | -2,94 -3,30 10.83% | -2,56 -3,30 22.51% | -3,10 -3,30 6.04% | -1,50 -3,10 51.61% | -3,20 | -3,20 | -3,10 | -3,00 |
|
Net income Million USD | Released Forecast Spread | -3,10 -3,26 4.85% | -2,86 -3,20 10.68% | -3,59 -3,00 -19.7% | -3,44 -3,50 1.71% | -3,29 -3,00 -9.65% | -2,94 -3,30 10.83% | -2,56 -3,30 22.51% | -3,10 -3,30 6.04% | -1,50 -3,10 51.61% | -3,20 | -3,20 | -3,10 | -3,00 |
|
EPS USD | Released Forecast Spread | -1,40 -1,60 12.5% | -1,40 -1,50 6.67% | -1,20 -1,10 -9.09% | -1,00 -1,10 9.09% | -0,96 -0,90 -6.67% | -0,93 -1,05 11% | -0,43 -0,55 21.82% | -0,40 -0,43 6.98% | -0,17 -0,36 52.78% | -0,37 | -0,36 | -0,35 | -0,33 |
| Announcement Date | 30/03/22 | 12/05/22 | 15/08/22 | 14/11/22 | 14/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 28/03/24 | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for ENDRA Life Sciences Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NDRA Stock
- Calendar ENDRA Life Sciences Inc.
